Latest News about BNTX
Recent news which mentions BNTX
   3 of the Best Bear Market Buys for August
   
  
  
  August 05, 2022
  From Motley Fool
 
   Official U.S. new case tally may be declining but at-home testing obscures data, and Novavax starts trial of vaccine for very young children
   
  
  
  August 05, 2022
  From MarketWatch
 
   Genmab, BioNTech Join Forces For Cancer Immunotherapy Candidates
   
  
  
  August 05, 2022
  From Benzinga
 
   A Flurry Of Employment News Drops Ahead Of Friday's Jobs Report
   
  
  
  August 04, 2022
  From Benzinga
 
   Here's Why BioNTech Stock Is Moving
   
  
  
  August 03, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Could the Fall Booster Market Boost Vaccine Stocks?
   
  
  
  August 02, 2022
  From Motley Fool
 From Motley Fool
 From Benzinga
 
   5 Value Stocks In The Healthcare Sector
   
  
  
  August 01, 2022
  From Benzinga
 
   Is The Energy Ready To Rebound?
   
  
  
  August 01, 2022
  From Benzinga
 
   Moderna and Pfizer to start clinical trials for COVID-19 boosters that target BA.5 ‘in the near future’
   
  
  
  July 29, 2022
  From MarketWatch
 From Motley Fool
 From Benzinga
 
   Research shows coronavirus pandemic originated in Wuhan wet market and did not escape from a Chinese lab
   
  
  
  July 27, 2022
  From MarketWatch
 From Motley Fool
 From Benzinga
 
   Overview Of Value Stocks In The Healthcare Sector
   
  
  
  July 25, 2022
  From Benzinga
 
   CDC OK’s Novavax vaccine to add fifth shot to U.S. program, and COVID cases triple in Europe in six-week span
   
  
  
  July 20, 2022
  From MarketWatch
 
   2 Things Novavax Must Do to Be a Monster Comeback Stock
   
  
  
  July 20, 2022
  From Motley Fool
 
   Why Moderna Stock Bumped Higher Today
   
  
  
  July 19, 2022
  From Motley Fool
 
   WHO, UNICEF Sound Alarm As Pandemic Leads Largest Fall In Kids Vaccinations In 30 Years
   
  
  
  July 18, 2022
  From Benzinga
 
   2 Top Biotech Stocks to Buy Right Now
   
  
  
  July 15, 2022
  From Motley Fool
 From Benzinga
 
   Novavax’s protein-based vaccine approval fails to boost stock as demand for shots and boosters remains low
   
  
  
  July 14, 2022
  From MarketWatch
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
